American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Te

Clifton Mining Company Inc. (OTC : CFTN)



SALT LAKE CITY, Oct. 9  /PRNewswire-FirstCall/ -- American Biotech Labs (ABL; http://www.americanbiotechlabs.com/), creator of a line of powerful products that utilize patented ABL SilverSol Technology(TM) to combat many of the world's most harmful pathogens, today announced successful preliminary results on tests performed using the company's products against three strains of the avian bird flu virus.

Preliminary in vitro tests performed by two separate independent laboratories, using the company's ABL SilverSol Technology(TM) at 10 parts per million against two strains of the H5-N1 and H3-N2 subtype of the Avian Bird Flu virus, indicated that the ABL products could neutralize the virus.

"While we understand that these are preliminary studies, we are extremely encouraged by the results of this initial testing," said Keith Moeller, a managing director at American Biotech Labs. "Our intent with these studies is to test the ability of the product to disarm or kill the Avian flu virus in a laboratory setting. It is a necessary and valuable next step in our continued efforts to gain an understanding of what this technology can do."

The preliminary results of the tests using ABL products against the H5N1 avian bird flu virus are consistent with a variety of previous tests conducted using company products against the H3N2 and H1N1 flu subtypes. In all cases, ABL SilverSol Technology(TM) was able to successfully neutralize the virus.

ABL is engaged in continuing testing and study programs with a variety of groups and labs in the United States and other nations examining the potential applications of ABL SilverSol Technology(TM).

About American Biotech Labs

American Biotech Labs (ABL; http://www.americanbiotechlabs.com/), founded in 1998, utilizes patented processes and technology to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's nano-catalytic silver hydrosol has consistently demonstrated the ability to destroy a wide range of microbes - bacteria, viruses and molds. ABL products can be found at GNC and other fine health food stores under the Silver Biotics(R) label.

Clifton Mining Company owns approximately 23% of ABL. Clifton trades on the U.S. OTC: (CFTN).

Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. 

DATASOURCE: Clifton Mining Company



CONTACT: Dr. Ken Friedman, President at [phone]; Keith Moeller,

Vice President at [phone] or see our website at http://www.cliftonmining.com/

Copyright